Clinical trial
Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly…
NCT00099125 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00099125 |
|---|---|
| Title | Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme |
| Official title | A Phase II Study Of Radiation Therapy Plus Low Dose Temozolomide Followed By Temozolomide Plus Irinotecan For Glioblastoma Multiforme |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | irinotecan hydrochloride, temozolomide, adjuvant therapy, radiation therapy |
| Enrollment | 170 |
| Start date | Nov 1, 2004 |
| Primary completion | Oct 1, 2006 |
| Completion | Nov 1, 2013 |
| First posted | Dec 9, 2004 |
| Last update posted | Jan 24, 2014 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: